Dear Slinger, I have no beef with you or any CYP holders.
I am invested in MSB, who on the record are about to resubmit their BLA to the FDA within the next 7 business days.
We had an article that came out from a highly regarded financial journo with many years of experience, that quoted his source being the CEO of MSB.
It was a positive article that some investors here hated, and as a result, doubted by emotion, they posted negative sentiments.
I would want to be the first for sure, however anyone thinking that it will be CYP needs a head scan.
Obtaining and extracting natural healthy original MSC's is getting easier as we progress with technology and the need to dangerously flirt with reproducing them in vitro mass quantities, like a condiment on a shelf, will not be looked at kindly by the FDA, or for that matter human activists once they wake up to it.
I like it, but it is a long long way away.
I will gladly be an investor in CYP in the future.
- Forums
- ASX - By Stock
- CYP
- Ann: Investor Presentation
CYP
cynata therapeutics limited
Add to My Watchlist
3.13%
!
15.5¢

Ann: Investor Presentation, page-537
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
15.5¢ |
Change
-0.005(3.13%) |
Mkt cap ! $35.02M |
Open | High | Low | Value | Volume |
16.0¢ | 16.5¢ | 15.5¢ | $22.43K | 139.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 15.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
16.0¢ | 9763 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 58708 | 0.155 |
5 | 106673 | 0.150 |
2 | 45000 | 0.140 |
1 | 10937 | 0.130 |
1 | 26000 | 0.115 |
Price($) | Vol. | No. |
---|---|---|
0.160 | 9763 | 1 |
0.165 | 38474 | 1 |
0.170 | 70000 | 2 |
0.175 | 77450 | 2 |
0.180 | 62619 | 3 |
Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
Featured News
CYP (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online